Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Clinical trial NCT06356584 · RECRUITING

Trial details

NCT number: NCT06356584
Sponsor: Shandong Cancer Hospital and Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Immunotherapy Radiotherapy Targeted Therapy Liver Metastasis

Start date: 2024-04-01
Primary completion: 2026-10-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.